ATRA
HealthcareAtara Biotherapeutics, Inc.
$6.29-0.61 (-8.88%)
Prev Close
$6.90
Open
$6.80
High
$7.00
Low
$6.21
Volume
160.0K
Market Cap
$48.2M
P/E
1.91
Div Yield
—
Over the past 12 months, insider activity at Atara Biotherapeutics, Inc. (ATRA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 9 insider sales totaling $695.6K. The most recent insider transaction was by Grant-Huerta Yanina (officer: Chief Accounting Officer), who sold $21.4K worth of shares on Mar 4, 2026. Atara Biotherapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $48.2M.
Buys (12M)
0
$0.00
Sells (12M)
9
$695.6K
Net Activity
Net Seller
$695.6K
Active Insiders
3
last 12 mo
ATRA Price Chart
ATRA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026↗ | Grant-Huerta Yanina | officer: Chief Accounting Officer | Sell | 4,208 | $5.08 | $21.4K | 33,830 |
| Mar 4, 2026↗ | Nguyen AnhCo | director, officer: President and CEO | Sell | 5,992 | $5.09 | $30.5K | 64,776 |
| Jan 14, 2026↗ | Panacea Innovation Ltd | 10 percent owner | Sell | 80,554 | $6.07 | $489.0K | 1,324,450 |
| Nov 17, 2025↗ | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 1,804 | $13.19 | $23.8K | 0 |
| Nov 17, 2025↗ | Nguyen AnhCo | President and CEO | Sell | 2,915 | $13.19 | $38.4K | 0 |
| Aug 18, 2025↗ | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 1,809 | $11.61 | $21.0K | 0 |
| Aug 18, 2025↗ | Nguyen AnhCo | President and CEO | Sell | 2,958 | $11.62 | $34.4K | 0 |
| May 16, 2025↗ | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 2,218 | $6.76 | $15.0K | 0 |
| May 16, 2025↗ | Nguyen AnhCo | President and CEO | Sell | 3,276 | $6.76 | $22.2K | 0 |
| Mar 3, 2025↗ | Henrich Jill | EVP, Chief Regulatory Officer | Sell | 1,059 | $7.00 | $7.4K | 0 |
| Mar 3, 2025↗ | Hyllengren Eric J | EVP, CFO and COO | Sell | 1,211 | $7.00 | $8.5K | 0 |
| Mar 3, 2025↗ | Nguyen AnhCo | President and CEO | Sell | 3,331 | $7.00 | $23.3K | 0 |
| Nov 18, 2024↗ | Henrich Jill | EVP, Chief Regulatory Officer | Sell | 1,000 | $11.20 | $11.2K | 0 |
| Nov 18, 2024↗ | Hyllengren Eric J | EVP, CFO and COO | Sell | 1,364 | $11.20 | $15.3K | 0 |
| Nov 18, 2024↗ | Nguyen AnhCo | President and CEO | Sell | 1,664 | $11.20 | $18.6K | 0 |
| Aug 16, 2024↗ | Henrich Jill | EVP, Global Head RA & Quality | Sell | 963 | $6.63 | $6.4K | 0 |
| Aug 16, 2024↗ | Hyllengren Eric J | EVP, CFO | Sell | 1,070 | $6.63 | $7.1K | 0 |
| Aug 16, 2024↗ | Murugan Amar | EVP, Chief Legal Officer | Sell | 1,158 | $6.63 | $7.7K | 0 |
| Aug 16, 2024↗ | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Sell | 1,821 | $6.63 | $12.1K | 0 |
| Aug 16, 2024↗ | Touchon Pascal | President and CEO | Sell | 3,038 | $6.63 | $20.1K | 0 |
| May 16, 2024↗ | Henrich Jill | EVP, Global Head RA & Quality | Sell | 25,750 | $0.62 | $15.9K | 0 |
| May 16, 2024↗ | Hyllengren Eric J | EVP, CFO | Sell | 28,648 | $0.62 | $17.7K | 0 |
| May 16, 2024↗ | Murugan Amar | EVP, Chief Legal Officer | Sell | 32,401 | $0.62 | $20.0K | 0 |
| May 16, 2024↗ | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Sell | 42,899 | $0.62 | $26.5K | 0 |
| May 16, 2024↗ | Touchon Pascal | President and CEO | Sell | 81,506 | $0.62 | $50.3K | 0 |
| Mar 4, 2024↗ | Henrich Jill | EVP, Global Head RA & Quality | Sell | 3,879 | $0.72 | $2.8K | 0 |
| Mar 4, 2024↗ | Hyllengren Eric J | EVP, CFO | Sell | 6,679 | $0.72 | $4.8K | 0 |
| Mar 4, 2024↗ | Murugan Amar | EVP, Chief Legal Officer | Sell | 10,044 | $0.72 | $7.2K | 0 |
| Mar 4, 2024↗ | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Sell | 10,746 | $0.72 | $7.7K | 0 |
| Mar 4, 2024↗ | Touchon Pascal | President and CEO | Sell | 24,844 | $0.72 | $17.9K | 0 |
| Nov 16, 2023↗ | Henrich Jill | EVP, Global Head RA & Quality | Sell | 3,267 | $0.39 | $1.3K | 0 |
| Nov 16, 2023↗ | Hyllengren Eric J | SVP, CFO | Sell | 11,958 | $0.39 | $4.7K | 0 |
| Nov 16, 2023↗ | Joshi Manher | EVP, Chief Medical Officer | Sell | 12,287 | $0.39 | $4.8K | 0 |
| Nov 16, 2023↗ | Murugan Amar | EVP, Chief Legal Officer | Sell | 8,307 | $0.39 | $3.2K | 0 |
| Nov 16, 2023↗ | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Sell | 8,856 | $0.39 | $3.4K | 0 |
| Nov 16, 2023↗ | Touchon Pascal | President and CEO | Sell | 20,409 | $0.39 | $7.9K | 0 |
| Nov 13, 2023↗ | Gallagher Carol Giltner | Director | Buy | 270,000 | $0.25 | $68.2K | 0 |
| Nov 10, 2023↗ | DOBMEIER ERIC | Director | Buy | 446,825 | $0.23 | $101.3K | 0 |
| Nov 10, 2023↗ | HEIDEN WILLIAM K | Director | Buy | 100,000 | $0.25 | $25.3K | 0 |
| Aug 16, 2023↗ | Henrich Jill | EVP, Global Head RA & Quality | Sell | 3,346 | $1.65 | $5.5K | 0 |
| Aug 16, 2023↗ | Hyllengren Eric J | SVP, CFO | Sell | 8,186 | $1.65 | $13.5K | 0 |
| Aug 16, 2023↗ | Joshi Manher | EVP, Chief Medical Officer | Sell | 6,975 | $1.65 | $11.5K | 0 |
| Aug 16, 2023↗ | Murugan Amar | EVP, Chief Legal Officer | Sell | 8,672 | $1.65 | $14.3K | 0 |
| Aug 16, 2023↗ | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Sell | 15,126 | $1.65 | $25.0K | 0 |
| Aug 16, 2023↗ | Touchon Pascal | President and CEO | Sell | 30,766 | $1.65 | $50.8K | 0 |
| Jun 27, 2023↗ | Touchon Pascal | President and CEO | Sell | 14,291 | $1.66 | $23.7K | 0 |
| May 16, 2023↗ | Banard Charlene A. | EVP, Chief Technical Officer | Sell | 19,040 | $2.04 | $38.8K | 0 |
| May 16, 2023↗ | Hyllengren Eric J | SVP, CFO | Sell | 7,918 | $2.04 | $16.1K | 0 |
| May 16, 2023↗ | Murugan Amar | EVP, Chief Legal Officer | Sell | 8,389 | $2.04 | $17.1K | 0 |
| May 16, 2023↗ | Touchon Pascal | President and CEO | Sell | 29,766 | $2.04 | $60.6K | 0 |
| Mar 2, 2023↗ | Dupont Jakob | EVP, Head of R&D | Sell | 5,074 | $3.63 | $18.4K | 0 |
| Mar 2, 2023↗ | Koppikar Utpal | Chief Financial Officer | Sell | 6,871 | $3.63 | $24.9K | 0 |
| Mar 2, 2023↗ | Murugan Amar | SVP, GC & Secretary | Sell | 4,221 | $3.63 | $15.3K | 0 |
| Mar 2, 2023↗ | Touchon Pascal | President and CEO | Sell | 15,679 | $3.63 | $56.9K | 0 |
| Feb 7, 2023↗ | Koppikar Utpal | Chief Financial Officer | Sell | 2,485 | $5.46 | $13.6K | 0 |
| Nov 16, 2022↗ | Dupont Jakob | EVP, Head of R&D | Sell | 4,342 | $4.49 | $19.5K | 0 |
| Nov 16, 2022↗ | Koppikar Utpal | Chief Financial Officer | Sell | 6,255 | $4.49 | $28.1K | 0 |
| Nov 16, 2022↗ | Murugan Amar | SVP, GC & Secretary | Sell | 3,612 | $4.49 | $16.2K | 0 |
| Nov 16, 2022↗ | Touchon Pascal | President and CEO | Sell | 15,591 | $4.49 | $70.0K | 0 |
| Aug 16, 2022↗ | Dupont Jakob | EVP, Head of R&D | Sell | 4,124 | $5.03 | $20.8K | 0 |
| Aug 16, 2022↗ | Koppikar Utpal | Chief Financial Officer | Sell | 5,940 | $5.04 | $29.9K | 0 |
| Aug 16, 2022↗ | Murugan Amar | SVP, GC & Secretary | Sell | 3,430 | $5.03 | $17.3K | 0 |
| Aug 16, 2022↗ | Touchon Pascal | President and CEO | Sell | 14,806 | $5.03 | $74.5K | 0 |
| Jun 27, 2022↗ | Touchon Pascal | President and CEO | Sell | 14,220 | $7.20 | $102.4K | 0 |
| Jun 8, 2022↗ | Koppikar Utpal | Chief Financial Officer | Sell | 5,853 | $5.63 | $33.0K | 0 |
| May 17, 2022↗ | Dupont Jakob | EVP, Head of R&D | Sell | 3,873 | $5.32 | $20.6K | 0 |
| May 17, 2022↗ | Koppikar Utpal | Chief Financial Officer | Sell | 5,582 | $5.32 | $29.7K | 0 |
| May 17, 2022↗ | Murugan Amar | SVP, GC & Secretary | Sell | 3,223 | $5.32 | $17.1K | 0 |
| May 17, 2022↗ | Touchon Pascal | President and CEO | Sell | 13,913 | $5.32 | $74.0K | 0 |
| Mar 1, 2022↗ | Dupont Jakob | EVP, Head of R&D | Sell | 2,221 | $9.86 | $21.9K | 0 |
| Mar 1, 2022↗ | Koppikar Utpal | Chief Financial Officer | Sell | 3,763 | $9.86 | $37.1K | 0 |
| Mar 1, 2022↗ | Murugan Amar | SVP, GC & Secretary | Sell | 2,577 | $9.86 | $25.4K | 0 |
| Mar 1, 2022↗ | Touchon Pascal | President and CEO | Sell | 8,828 | $9.86 | $87.0K | 0 |
| Feb 10, 2022↗ | Dupont Jakob | EVP, Head of R&D | Sell | 5,000 | $16.00 | $80.0K | 0 |
| Feb 7, 2022↗ | Koppikar Utpal | Chief Financial Officer | Sell | 2,496 | $14.46 | $36.1K | 0 |
| Jan 3, 2022↗ | Dupont Jakob | EVP, Head of R&D | Sell | 5,000 | $16.01 | $80.0K | 0 |
| Dec 1, 2021↗ | Dupont Jakob | EVP, Head of R&D | Sell | 5,000 | $17.94 | $89.7K | 0 |
| Nov 16, 2021↗ | Dupont Jakob | EVP, Head of R&D | Sell | 2,199 | $17.12 | $37.6K | 0 |
| Nov 16, 2021↗ | Koppikar Utpal | Chief Financial Officer | Sell | 3,655 | $17.12 | $62.6K | 0 |
| Nov 16, 2021↗ | Murugan Amar | SVP, GC & Secretary | Sell | 2,124 | $17.12 | $36.4K | 0 |
| Nov 16, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 3,332 | $17.12 | $57.0K | 0 |
| Nov 16, 2021↗ | Touchon Pascal | President and CEO | Sell | 8,402 | $17.12 | $143.8K | 0 |
| Nov 15, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 7,000 | $17.71 | $124.0K | 0 |
| Nov 4, 2021↗ | Fust Matthew K | Director | Sell | 13,354 | $19.50 | $260.4K | 0 |
| Nov 2, 2021↗ | Dupont Jakob | EVP, Head of R&D | Sell | 5,000 | $16.41 | $82.0K | 0 |
| Sep 22, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 10,500 | $17.00 | $178.5K | 0 |
| Sep 15, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 3,116 | $15.61 | $48.6K | 0 |
| Aug 30, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 3,500 | $15.00 | $52.5K | 0 |
| Aug 17, 2021↗ | Dupont Jakob | EVP, Head of R&D | Sell | 2,152 | $12.53 | $27.0K | 0 |
| Aug 17, 2021↗ | Koppikar Utpal | Chief Financial Officer | Sell | 3,579 | $12.53 | $44.9K | 0 |
| Aug 17, 2021↗ | Murugan Amar | SVP, GC & Secretary | Sell | 2,080 | $12.53 | $26.1K | 0 |
| Aug 17, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 2,426 | $12.53 | $30.4K | 0 |
| Aug 17, 2021↗ | Touchon Pascal | President and CEO | Sell | 8,223 | $12.53 | $103.1K | 0 |
| Jun 25, 2021↗ | Touchon Pascal | President and CEO | Sell | 14,194 | $16.32 | $231.7K | 0 |
| Jun 11, 2021↗ | Yarema Kristin | Chief Commercial Officer | Buy | 34,354 | $14.57 | $500.4K | 0 |
| Jun 8, 2021↗ | Koppikar Utpal | Chief Financial Officer | Sell | 5,820 | $14.06 | $81.8K | 0 |
| May 18, 2021↗ | Dupont Jakob | EVP, Head of R&D | Sell | 5,184 | $14.55 | $75.4K | 0 |
| May 18, 2021↗ | Koppikar Utpal | Chief Financial Officer | Sell | 3,616 | $14.55 | $52.6K | 0 |
| May 18, 2021↗ | Murugan Amar | SVP, GC & Secretary | Sell | 5,681 | $14.55 | $82.7K | 0 |
| May 18, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 2,453 | $14.55 | $35.7K | 0 |
| May 18, 2021↗ | Touchon Pascal | President and CEO | Sell | 8,313 | $14.55 | $121.0K | 0 |
| May 18, 2021↗ | Yarema Kristin | Chief Commercial Officer | Sell | 761 | $14.55 | $11.1K | 0 |
| May 17, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 3,500 | $15.00 | $52.5K | 0 |
| Apr 5, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 655 | $14.74 | $9.7K | 0 |
| Mar 26, 2021↗ | Koppikar Utpal | Chief Financial Officer | Sell | 1,761 | $14.58 | $25.7K | 0 |
| Mar 26, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 2,640 | $14.58 | $38.5K | 0 |
| Mar 15, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 7,000 | $17.41 | $121.9K | 0 |
| Mar 2, 2021↗ | Koppikar Utpal | Chief Financial Officer | Sell | 1,461 | $16.74 | $24.5K | 0 |
| Mar 2, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 1,665 | $16.74 | $27.9K | 0 |
| Mar 2, 2021↗ | Touchon Pascal | President and CEO | Sell | 4,887 | $16.74 | $81.8K | 0 |
ATRA Insider Buying Activity
The following table shows recent insider purchases of Atara Biotherapeutics, Inc. (ATRA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 13, 2023↗ | Gallagher Carol Giltner | Director | Buy | 270,000 | $0.25 | $68.2K | 0 |
| Nov 10, 2023↗ | DOBMEIER ERIC | Director | Buy | 446,825 | $0.23 | $101.3K | 0 |
| Nov 10, 2023↗ | HEIDEN WILLIAM K | Director | Buy | 100,000 | $0.25 | $25.3K | 0 |
| Jun 11, 2021↗ | Yarema Kristin | Chief Commercial Officer | Buy | 34,354 | $14.57 | $500.4K | 0 |
ATRA Insider Selling Activity
The following table shows recent insider sales of Atara Biotherapeutics, Inc. (ATRA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026↗ | Grant-Huerta Yanina | officer: Chief Accounting Officer | Sell | 4,208 | $5.08 | $21.4K | 33,830 |
| Mar 4, 2026↗ | Nguyen AnhCo | director, officer: President and CEO | Sell | 5,992 | $5.09 | $30.5K | 64,776 |
| Jan 14, 2026↗ | Panacea Innovation Ltd | 10 percent owner | Sell | 80,554 | $6.07 | $489.0K | 1,324,450 |
| Nov 17, 2025↗ | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 1,804 | $13.19 | $23.8K | 0 |
| Nov 17, 2025↗ | Nguyen AnhCo | President and CEO | Sell | 2,915 | $13.19 | $38.4K | 0 |
| Aug 18, 2025↗ | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 1,809 | $11.61 | $21.0K | 0 |
| Aug 18, 2025↗ | Nguyen AnhCo | President and CEO | Sell | 2,958 | $11.62 | $34.4K | 0 |
| May 16, 2025↗ | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 2,218 | $6.76 | $15.0K | 0 |
| May 16, 2025↗ | Nguyen AnhCo | President and CEO | Sell | 3,276 | $6.76 | $22.2K | 0 |
| Mar 3, 2025↗ | Henrich Jill | EVP, Chief Regulatory Officer | Sell | 1,059 | $7.00 | $7.4K | 0 |
| Mar 3, 2025↗ | Hyllengren Eric J | EVP, CFO and COO | Sell | 1,211 | $7.00 | $8.5K | 0 |
| Mar 3, 2025↗ | Nguyen AnhCo | President and CEO | Sell | 3,331 | $7.00 | $23.3K | 0 |
| Nov 18, 2024↗ | Henrich Jill | EVP, Chief Regulatory Officer | Sell | 1,000 | $11.20 | $11.2K | 0 |
| Nov 18, 2024↗ | Hyllengren Eric J | EVP, CFO and COO | Sell | 1,364 | $11.20 | $15.3K | 0 |
| Nov 18, 2024↗ | Nguyen AnhCo | President and CEO | Sell | 1,664 | $11.20 | $18.6K | 0 |
| Aug 16, 2024↗ | Henrich Jill | EVP, Global Head RA & Quality | Sell | 963 | $6.63 | $6.4K | 0 |
| Aug 16, 2024↗ | Hyllengren Eric J | EVP, CFO | Sell | 1,070 | $6.63 | $7.1K | 0 |
| Aug 16, 2024↗ | Murugan Amar | EVP, Chief Legal Officer | Sell | 1,158 | $6.63 | $7.7K | 0 |
| Aug 16, 2024↗ | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Sell | 1,821 | $6.63 | $12.1K | 0 |
| Aug 16, 2024↗ | Touchon Pascal | President and CEO | Sell | 3,038 | $6.63 | $20.1K | 0 |
| May 16, 2024↗ | Henrich Jill | EVP, Global Head RA & Quality | Sell | 25,750 | $0.62 | $15.9K | 0 |
| May 16, 2024↗ | Hyllengren Eric J | EVP, CFO | Sell | 28,648 | $0.62 | $17.7K | 0 |
| May 16, 2024↗ | Murugan Amar | EVP, Chief Legal Officer | Sell | 32,401 | $0.62 | $20.0K | 0 |
| May 16, 2024↗ | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Sell | 42,899 | $0.62 | $26.5K | 0 |
| May 16, 2024↗ | Touchon Pascal | President and CEO | Sell | 81,506 | $0.62 | $50.3K | 0 |
| Mar 4, 2024↗ | Henrich Jill | EVP, Global Head RA & Quality | Sell | 3,879 | $0.72 | $2.8K | 0 |
| Mar 4, 2024↗ | Hyllengren Eric J | EVP, CFO | Sell | 6,679 | $0.72 | $4.8K | 0 |
| Mar 4, 2024↗ | Murugan Amar | EVP, Chief Legal Officer | Sell | 10,044 | $0.72 | $7.2K | 0 |
| Mar 4, 2024↗ | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Sell | 10,746 | $0.72 | $7.7K | 0 |
| Mar 4, 2024↗ | Touchon Pascal | President and CEO | Sell | 24,844 | $0.72 | $17.9K | 0 |
| Nov 16, 2023↗ | Henrich Jill | EVP, Global Head RA & Quality | Sell | 3,267 | $0.39 | $1.3K | 0 |
| Nov 16, 2023↗ | Hyllengren Eric J | SVP, CFO | Sell | 11,958 | $0.39 | $4.7K | 0 |
| Nov 16, 2023↗ | Joshi Manher | EVP, Chief Medical Officer | Sell | 12,287 | $0.39 | $4.8K | 0 |
| Nov 16, 2023↗ | Murugan Amar | EVP, Chief Legal Officer | Sell | 8,307 | $0.39 | $3.2K | 0 |
| Nov 16, 2023↗ | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Sell | 8,856 | $0.39 | $3.4K | 0 |
| Nov 16, 2023↗ | Touchon Pascal | President and CEO | Sell | 20,409 | $0.39 | $7.9K | 0 |
| Aug 16, 2023↗ | Henrich Jill | EVP, Global Head RA & Quality | Sell | 3,346 | $1.65 | $5.5K | 0 |
| Aug 16, 2023↗ | Hyllengren Eric J | SVP, CFO | Sell | 8,186 | $1.65 | $13.5K | 0 |
| Aug 16, 2023↗ | Joshi Manher | EVP, Chief Medical Officer | Sell | 6,975 | $1.65 | $11.5K | 0 |
| Aug 16, 2023↗ | Murugan Amar | EVP, Chief Legal Officer | Sell | 8,672 | $1.65 | $14.3K | 0 |
| Aug 16, 2023↗ | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Sell | 15,126 | $1.65 | $25.0K | 0 |
| Aug 16, 2023↗ | Touchon Pascal | President and CEO | Sell | 30,766 | $1.65 | $50.8K | 0 |
| Jun 27, 2023↗ | Touchon Pascal | President and CEO | Sell | 14,291 | $1.66 | $23.7K | 0 |
| May 16, 2023↗ | Banard Charlene A. | EVP, Chief Technical Officer | Sell | 19,040 | $2.04 | $38.8K | 0 |
| May 16, 2023↗ | Hyllengren Eric J | SVP, CFO | Sell | 7,918 | $2.04 | $16.1K | 0 |
| May 16, 2023↗ | Murugan Amar | EVP, Chief Legal Officer | Sell | 8,389 | $2.04 | $17.1K | 0 |
| May 16, 2023↗ | Touchon Pascal | President and CEO | Sell | 29,766 | $2.04 | $60.6K | 0 |
| Mar 2, 2023↗ | Dupont Jakob | EVP, Head of R&D | Sell | 5,074 | $3.63 | $18.4K | 0 |
| Mar 2, 2023↗ | Koppikar Utpal | Chief Financial Officer | Sell | 6,871 | $3.63 | $24.9K | 0 |
| Mar 2, 2023↗ | Murugan Amar | SVP, GC & Secretary | Sell | 4,221 | $3.63 | $15.3K | 0 |
| Mar 2, 2023↗ | Touchon Pascal | President and CEO | Sell | 15,679 | $3.63 | $56.9K | 0 |
| Feb 7, 2023↗ | Koppikar Utpal | Chief Financial Officer | Sell | 2,485 | $5.46 | $13.6K | 0 |
| Nov 16, 2022↗ | Dupont Jakob | EVP, Head of R&D | Sell | 4,342 | $4.49 | $19.5K | 0 |
| Nov 16, 2022↗ | Koppikar Utpal | Chief Financial Officer | Sell | 6,255 | $4.49 | $28.1K | 0 |
| Nov 16, 2022↗ | Murugan Amar | SVP, GC & Secretary | Sell | 3,612 | $4.49 | $16.2K | 0 |
| Nov 16, 2022↗ | Touchon Pascal | President and CEO | Sell | 15,591 | $4.49 | $70.0K | 0 |
| Aug 16, 2022↗ | Dupont Jakob | EVP, Head of R&D | Sell | 4,124 | $5.03 | $20.8K | 0 |
| Aug 16, 2022↗ | Koppikar Utpal | Chief Financial Officer | Sell | 5,940 | $5.04 | $29.9K | 0 |
| Aug 16, 2022↗ | Murugan Amar | SVP, GC & Secretary | Sell | 3,430 | $5.03 | $17.3K | 0 |
| Aug 16, 2022↗ | Touchon Pascal | President and CEO | Sell | 14,806 | $5.03 | $74.5K | 0 |
| Jun 27, 2022↗ | Touchon Pascal | President and CEO | Sell | 14,220 | $7.20 | $102.4K | 0 |
| Jun 8, 2022↗ | Koppikar Utpal | Chief Financial Officer | Sell | 5,853 | $5.63 | $33.0K | 0 |
| May 17, 2022↗ | Dupont Jakob | EVP, Head of R&D | Sell | 3,873 | $5.32 | $20.6K | 0 |
| May 17, 2022↗ | Koppikar Utpal | Chief Financial Officer | Sell | 5,582 | $5.32 | $29.7K | 0 |
| May 17, 2022↗ | Murugan Amar | SVP, GC & Secretary | Sell | 3,223 | $5.32 | $17.1K | 0 |
| May 17, 2022↗ | Touchon Pascal | President and CEO | Sell | 13,913 | $5.32 | $74.0K | 0 |
| Mar 1, 2022↗ | Dupont Jakob | EVP, Head of R&D | Sell | 2,221 | $9.86 | $21.9K | 0 |
| Mar 1, 2022↗ | Koppikar Utpal | Chief Financial Officer | Sell | 3,763 | $9.86 | $37.1K | 0 |
| Mar 1, 2022↗ | Murugan Amar | SVP, GC & Secretary | Sell | 2,577 | $9.86 | $25.4K | 0 |
| Mar 1, 2022↗ | Touchon Pascal | President and CEO | Sell | 8,828 | $9.86 | $87.0K | 0 |
| Feb 10, 2022↗ | Dupont Jakob | EVP, Head of R&D | Sell | 5,000 | $16.00 | $80.0K | 0 |
| Feb 7, 2022↗ | Koppikar Utpal | Chief Financial Officer | Sell | 2,496 | $14.46 | $36.1K | 0 |
| Jan 3, 2022↗ | Dupont Jakob | EVP, Head of R&D | Sell | 5,000 | $16.01 | $80.0K | 0 |
| Dec 1, 2021↗ | Dupont Jakob | EVP, Head of R&D | Sell | 5,000 | $17.94 | $89.7K | 0 |
| Nov 16, 2021↗ | Dupont Jakob | EVP, Head of R&D | Sell | 2,199 | $17.12 | $37.6K | 0 |
| Nov 16, 2021↗ | Koppikar Utpal | Chief Financial Officer | Sell | 3,655 | $17.12 | $62.6K | 0 |
| Nov 16, 2021↗ | Murugan Amar | SVP, GC & Secretary | Sell | 2,124 | $17.12 | $36.4K | 0 |
| Nov 16, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 3,332 | $17.12 | $57.0K | 0 |
| Nov 16, 2021↗ | Touchon Pascal | President and CEO | Sell | 8,402 | $17.12 | $143.8K | 0 |
| Nov 15, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 7,000 | $17.71 | $124.0K | 0 |
| Nov 4, 2021↗ | Fust Matthew K | Director | Sell | 13,354 | $19.50 | $260.4K | 0 |
| Nov 2, 2021↗ | Dupont Jakob | EVP, Head of R&D | Sell | 5,000 | $16.41 | $82.0K | 0 |
| Sep 22, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 10,500 | $17.00 | $178.5K | 0 |
| Sep 15, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 3,116 | $15.61 | $48.6K | 0 |
| Aug 30, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 3,500 | $15.00 | $52.5K | 0 |
| Aug 17, 2021↗ | Dupont Jakob | EVP, Head of R&D | Sell | 2,152 | $12.53 | $27.0K | 0 |
| Aug 17, 2021↗ | Koppikar Utpal | Chief Financial Officer | Sell | 3,579 | $12.53 | $44.9K | 0 |
| Aug 17, 2021↗ | Murugan Amar | SVP, GC & Secretary | Sell | 2,080 | $12.53 | $26.1K | 0 |
| Aug 17, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 2,426 | $12.53 | $30.4K | 0 |
| Aug 17, 2021↗ | Touchon Pascal | President and CEO | Sell | 8,223 | $12.53 | $103.1K | 0 |
| Jun 25, 2021↗ | Touchon Pascal | President and CEO | Sell | 14,194 | $16.32 | $231.7K | 0 |
| Jun 8, 2021↗ | Koppikar Utpal | Chief Financial Officer | Sell | 5,820 | $14.06 | $81.8K | 0 |
| May 18, 2021↗ | Dupont Jakob | EVP, Head of R&D | Sell | 5,184 | $14.55 | $75.4K | 0 |
| May 18, 2021↗ | Koppikar Utpal | Chief Financial Officer | Sell | 3,616 | $14.55 | $52.6K | 0 |
| May 18, 2021↗ | Murugan Amar | SVP, GC & Secretary | Sell | 5,681 | $14.55 | $82.7K | 0 |
| May 18, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 2,453 | $14.55 | $35.7K | 0 |
| May 18, 2021↗ | Touchon Pascal | President and CEO | Sell | 8,313 | $14.55 | $121.0K | 0 |
| May 18, 2021↗ | Yarema Kristin | Chief Commercial Officer | Sell | 761 | $14.55 | $11.1K | 0 |
| May 17, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 3,500 | $15.00 | $52.5K | 0 |
| Apr 5, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 655 | $14.74 | $9.7K | 0 |
| Mar 26, 2021↗ | Koppikar Utpal | Chief Financial Officer | Sell | 1,761 | $14.58 | $25.7K | 0 |
| Mar 26, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 2,640 | $14.58 | $38.5K | 0 |
| Mar 15, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 7,000 | $17.41 | $121.9K | 0 |
| Mar 2, 2021↗ | Koppikar Utpal | Chief Financial Officer | Sell | 1,461 | $16.74 | $24.5K | 0 |
| Mar 2, 2021↗ | Newell Joe | Chief Operations Officer | Sell | 1,665 | $16.74 | $27.9K | 0 |
| Mar 2, 2021↗ | Touchon Pascal | President and CEO | Sell | 4,887 | $16.74 | $81.8K | 0 |
ATRA Insiders
Similar Stocks to ATRA
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B